These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15869060)

  • 21. Time course of faecal calprotectin in preterm newborns during the first month of life.
    Campeotto F; Kalach N; Lapillonne A; Butel MJ; Dupont C; Kapel N
    Acta Paediatr; 2007 Oct; 96(10):1531-3. PubMed ID: 17714537
    [No Abstract]   [Full Text] [Related]  

  • 22. Faecal calprotectin for the diagnosis of inflammatory bowel disease.
    Logan R
    BMJ; 2010 Jul; 341():c3636. PubMed ID: 20634348
    [No Abstract]   [Full Text] [Related]  

  • 23. Intestinal flora in very low-birth weight infants.
    Björkström MV; Hall L; Söderlund S; Håkansson EG; Håkansson S; Domellöf M
    Acta Paediatr; 2009 Nov; 98(11):1762-7. PubMed ID: 19673724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.
    Gisbert JP; McNicholl AG
    Dig Liver Dis; 2009 Jan; 41(1):56-66. PubMed ID: 18602356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Point-of-Care Fecal Calprotectin Monitoring in Preterm Infants at Risk for Necrotizing Enterocolitis.
    Nakayuenyongsuk W; Christofferson M; Stevenson DK; Sylvester K; Lee HC; Park KT
    J Pediatr; 2018 May; 196():98-103.e1. PubMed ID: 29519542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Faecal calprotectin in term and preterm neonates.
    Kapel N; Campeotto F; Kalach N; Baldassare M; Butel MJ; Dupont C
    J Pediatr Gastroenterol Nutr; 2010 Nov; 51(5):542-7. PubMed ID: 20818270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Measurement of calprotectin in faeces].
    Jahnsen J; Røseth AG; Aadland E
    Tidsskr Nor Laegeforen; 2009 Apr; 129(8):743-5. PubMed ID: 19373299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease.
    Reinders CA; Jonkers D; Janson EA; Stockbrügger RW; Stobberingh EE; Hellström PM; Lundberg JO
    Scand J Gastroenterol; 2007 Oct; 42(10):1151-7. PubMed ID: 17852876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serial fecal calprotectin in the prediction of necrotizing enterocolitis in preterm neonates.
    van Zoonen AGJF; Hulzebos CV; Muller Kobold AC; Kooi EMW; Bos AF; Hulscher JBF
    J Pediatr Surg; 2019 Mar; 54(3):455-459. PubMed ID: 29859621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid fecal calprotectin (FC) analysis: point of care testing for diagnosing early necrotizing enterocolitis.
    Bin-Nun A; Booms C; Sabag N; Mevorach R; Algur N; Hammerman C
    Am J Perinatol; 2015 Mar; 32(4):337-42. PubMed ID: 25111039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipocalin-2 and calprotectin as stool biomarkers for predicting necrotizing enterocolitis in premature neonates.
    Thibault MP; Tremblay É; Horth C; Fournier-Morin A; Grynspan D; Babakissa C; Levy E; Ferretti E; Bertelle V; Beaulieu JF
    Pediatr Res; 2022 Jan; 91(1):129-136. PubMed ID: 34465872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Value of combined measurement of intestinal fatty acid-binding protein and fecal calprotectin in diagnosis of necrotizing enterocolitis in full-term neonates].
    Tian YF; Li L; Mi HY; Huang-Pu CR; He S; Xu XY; Cao YJ
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 Nov; 18(11):1080-1083. PubMed ID: 27817769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of fecal calprotectin test in the work-up of IBS patients.
    Delgado-Aros S; Cremonini F
    Gastroenterology; 2003 Apr; 124(4):1164-5. PubMed ID: 12671919
    [No Abstract]   [Full Text] [Related]  

  • 34. Limited value of fecal calprotectin in patients with liver cirrhosis.
    Burri E; Manz M; Rieder S; Beglinger C
    Scand J Gastroenterol; 2011 Dec; 46(12):1527-8. PubMed ID: 21905979
    [No Abstract]   [Full Text] [Related]  

  • 35. Review of fecal biomarkers in inflammatory bowel disease.
    Sutherland AD; Gearry RB; Frizelle FA
    Dis Colon Rectum; 2008 Aug; 51(8):1283-91. PubMed ID: 18543035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noninvasive biomarkers of necrotizing enterocolitis.
    Nantais-Smith L; Kadrofske M
    J Perinat Neonatal Nurs; 2015; 29(1):69-80. PubMed ID: 25633402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis.
    Johnson MW; Maestranzi S; Duffy AM; Dewar DH; Forbes A; Bjarnason I; Sherwood RA; Ciclitira P; Nicholls JR
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):174-9. PubMed ID: 18301296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomarkers of necrotising enterocolitis.
    Ng PC
    Semin Fetal Neonatal Med; 2014 Feb; 19(1):33-8. PubMed ID: 24080072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Technology insight: calprotectin, lactoferrin and nitric oxide as novel markers of inflammatory bowel disease.
    Lundberg JO; Hellström PM; Fagerhol MK; Weitzberg E; Roseth AG
    Nat Clin Pract Gastroenterol Hepatol; 2005 Feb; 2(2):96-102. PubMed ID: 16265127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory biomarkers predict relapse in IBD.
    Hanaway P; Roseth A
    Gut; 2005 Sep; 54(9):1346-7. PubMed ID: 16099806
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.